TUG1 and acute kidney injury: The USC-Exo effectively ameliorate IRI-AKI, as evidenced by reduced serum markers, improved kidney morphology, and altered levels of ferroptosis-related factors through suppressing the expression of ACSL4 (Figure 4), a key contributor to ferroptosis, through a mechanism involving the interaction between TUG1 and RNA-binding protein SRSF1.